Abstract
Mesenteric venous thrombosis (MVT) is an unusual site of deep venous thrombosis. Little is known about risk factors of MVT, but available data seem to confirm a pathogenetic role of acquired thrombotic risk factors as well as inherited thrombotic risk factors. However, few cases on the association of MVT with oral contraceptive use have been described. We here report a case of MVT in a woman on oral contraception with fine and complete resolution after a fast diagnosis with abdominal ultrasound imaging and prompt therapy based on low molecular weight heparin.
MeSH terms
-
Administration, Oral
-
Adult
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use
-
Contraceptives, Oral / adverse effects*
-
Female
-
Follow-Up Studies
-
Heparin, Low-Molecular-Weight / therapeutic use*
-
Humans
-
Mesenteric Vascular Occlusion / chemically induced
-
Mesenteric Vascular Occlusion / diagnosis
-
Mesenteric Vascular Occlusion / diagnostic imaging
-
Mesenteric Vascular Occlusion / drug therapy*
-
Mesenteric Veins
-
Time Factors
-
Treatment Outcome
-
Ultrasonography
-
Venous Thrombosis / chemically induced
-
Venous Thrombosis / diagnosis
-
Venous Thrombosis / diagnostic imaging
-
Venous Thrombosis / drug therapy*
-
Warfarin / administration & dosage
-
Warfarin / therapeutic use
-
White People
Substances
-
Anticoagulants
-
Contraceptives, Oral
-
Heparin, Low-Molecular-Weight
-
Warfarin